PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury.

Rat / Crush

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32567690 ↗2020Reported benefit

An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury.

RatCrushLimb / muscle crushSprague-DawleyMaleInjection (liposome prepared by thin-film dispersion method)After muscle injury

Model: Acute blunt skeletal muscle injury

Icariin liposome promoted MHCIIB, vimentin and desmin expression, reduced collagen I, lowered TNF-alpha and IL-6, reduced malondialdehyde and increased superoxide dismutase activity, indicating improved muscle repair.

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.